Company profile
Anika Therapeutics, Inc.
NASDAQ:ANIKMedical/Dental Instruments
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03390036 | phase3 | completed | 2017-12-07 | 2018-07-30 | Anika Therapeutics, Inc. | Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up |
| NCT04231318 | phase3 | completed | 2020-09-11 | 2022-05-16 | Anika Therapeutics, Inc. | Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain |
| NCT03191903 | phase3 | completed | 2017-05-25 | 2018-04-23 | Anika Therapeutics, Inc. | Study of Cingalâ„¢ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide |
FDA applications (0)
No records yet.